Kane Black
Angel Investor
Singapore, Singapore
Kane Black is a angel investor in Singapore focused on Medical and Genetics. Kane Black is the founder of Severn Capital, a Singapore-headquartered principal investment and strategic transactions firm active across London, Asia and international capital markets. He has more than 20 years of operating, investment and corporate experience across Asia and international markets, spanning principal investment, public companies, healthcare, technology and cross-border transactions. His career has included building and leading businesses across Southeast and North Asia, executing acquisitions and strategic partnerships, and working with institutional, family-office and private capital. Kane previously served as Chief Executive of London Stock Exchange-listed Ikigai Ventures Limited (LON:IKIV), where he led the company through the acquisition of Dotlines Global (LON:DOTL) and the associated reverse takeover and readmission to the London market. He remains active across London public markets through the origination and execution of acquisitions, reverse takeovers, capital raisings and other strategic transactions. Earlier in his career, Kane held senior executive roles across the medical diagnostics sector in Singapore and the wider Asia-Pacific region, including Chief Executive roles at INEX Innovate and iGene Laboratory. During this period he led expansion across regional markets, strategic partnerships and corporate development initiatives. He was named EY Singapore Entrepreneur of the Year – Biotechnology in 2022. Kane is also a Non-Executive Director of INEX Innovate, a member of the NUS Medicine International Council and the Hong Kong Biotechnology Organisation. Through Severn Capital, he focuses on principal investment and strategic transactions involving public and private companies, with particular interests in natural resources, technology, healthcare and industrial businesses. The firm also works with companies and asset owners considering access to the London and Canadian public markets, including through acquisitions and reverse takeovers.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Kane Black invests in
Stages Kane Black invests in
Countries Kane Black invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Genetics 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Nova Satra Dx is a molecular diagnostics company headquartered in Singapore. The company is committed to empowering patients and physicians through the research, development and commercialisation of novel blood based diagnostic tests. These tests provide rapid and accurate detection of cancer using Asian-specific epigenetic biomarkers. Based onits clinically validated NovoTect™ technology developed by the University of Oxford, Nova Satra’s diagnostic tests can detect and identify changes in gene expression which are linked to cancer. The company is developing a pipeline of tests for breast, colon, prostate, stomach and lung cancers. For more information, please visit www.novasatra.com | $500K / Angel / Oct 01, 2014 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Kane Black invest in?
Kane Black invests primarily in Medical, Genetics and Health Diagnostics startups, most often at Angel stage. Most of the 1 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kane Black?
Public channels for Kane Black include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kane Black last invest?
The most recent investment recorded for Kane Black closed in Oct 2014. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
